Vertex Pharmaceuticals and CRISPR Therapeutics Amend Collaboration for Development, apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
APOL1 Mediated Kidney Disease Market Complete Analytical Report for 2030 with Key Players- Vertex Ph pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
5 Best Biotech Stocks To Buy For 2021
5. Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX)
Vertex Pharmaceuticals (NASDAQ: VRTX) is a Boston-based firm that aims to develop and manufacture transformative medicine for people with serious diseases. It has a market cap of well over $55 billion and generates an annual revenue of well over $6 billion. In fact, in 2020, the revenue soared 50% compared to the previous year. The company enjoys a monopoly in treating cystic fibrosis and presently markets four drugs related to the disease. A new drug in this group has soared to incredible highs in the US and is now slated for worldwide growth.
Vertex Pharmaceuticals Incorporated: Vertex Receives CHMP Positive Opinion for KAFTRIO (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor to Treat People With Cystic Fibrosis With At Least One F508del Mutation finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.